Medical Advocates
HIV Infection/Disease
  CNS Disorders
General Reports
 Diagnostics
 Cerebrospinal Fluid Studies
 Spinal Cord Disorders
 Immune Reconstitution Syndrome
 Leukoencephalopathy
 Myelopathy
 Brain Disorders
CNS Lymphomas
Neurocysticercosis
Paraparesis
Multifocal Leukoencephalopathy





 
Nervous System  Main Page Main New/Newsworthy Home Page

Last Update: October 31, 2008
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
General Reports
       
         Journal Papers, Abstracts, and Commentaries
 
 
Profile of Central Nervous System Disease in HIV/AIDS Patients With Special Reference to Cryptococcal
Infections.
Wadhwa A, Kaur R, Bhalla P.
Neurologist. 2008 Jul;14(4):247-51
 Abstract
 
Antiretroviral therapy and central nervous system HIV type 1 infection.
Price RW, Spudich S.  J
 Infect Dis. 2008 May 15;197 Suppl 3:S294-306.
 Abstract
 
Adaptation of antiretroviral therapy in human immunodeficiency virus infection with central
nervous system involvement.
Mehling M, Drechsler H, Kuhle J, et al
Neurovirol. 2008 Jan;14(1):78-84.
 Abstract
 
Biomarkers of HIV related central nervous system disease.
Brew BJ, Letendre SL  
Int Rev Psychiatry. 2008 Feb;20(1):73-88.
 Abstract
 
'Neurobiology of HIV.
 Hult B, Chana G, Masliah E, Everall I.
 Int Rev Psychiatry. 2008 Feb;20(1):3-13.
 Abstract
 
The Neuropathology of HIV/AIDS.
 Anthony IC, Bell JE.  
 Int Rev Psychiatry. 2008 Feb;20(1):15-24.
 Abstract

Neuropsychological impairment and the natural history of HIV-1 infection in Spanish subjects.
Rodriguez Alvarez M, Failde Garrdido JM, Simon Lopez MA.
 Funct Neurol. 2007 Jul-Sep;22(3):165-70
 Abstract

Updated research nosology for HIV-associated neurocognitive disorders.
Antinori A, Arendt G, Becker JT, et al   
Neurology. 2007 Oct 3;
 Abstract
 
The medical management of central nervous system infections in Uganda and the potential
impact of an algorithm-based approach to improve outcomes.
Trachtenberg JD, Kambugu AD, McKellar M, et al
Int J Infect Dis. 2007 May 17;
Abstract
 
Neuropathologic contributions to understanding AIDS and the central nervous system.
Scaravilli F, Bazille C, Gray F.
 Brain Pathol. 2007 Apr;17(2):197-208
 Abstract
 
Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and
neurological status in human immunodeficiency virus type 1 infection-The Hawaii Aging
with HIV Cohort.
Valcour V, Yee P, Williams A, et al 
J Neurovirol. 2006 Oct;12(5):387-91.
 Abstract
 
HIV and the central nervous system.
Moulignier A.   
Rev Neurol (Paris). 2006 Jan;162(1):22-42
 Abstract
 
FULL-TEXT ARTICLE
 Neuropsychiatric manifestations of HIV infection and AIDS.
Dube B, Benton T, Cruess DG, Evans DL.
J Psychiatry Neurosci. 2005 Jul;30(4):237-46
 Paper
 
Central nervous system infections in HIV patients in the era of high activity antiretroviral
treatment.
Rivas Gonzalez P, Fernandez Guerrero ML.
Rev Clin Esp. 2005 Jun;205(6):278-82.
 Abstract
 
 
      Conference Reports, Abstracts, and Posters
 
  Baseline Data from ACTG 5199: The International Neurological Study
K Robertson J Kumwenda, K Supparatpinyo, et al
(15 CROI)
Abstract
Diagnostics
       
         Journal Papers, Abstracts, and Commentaries
 
 
The imaging appearances of intracranial CNS infections in adult HIV and AIDS patients.
Offiah CE, Turnbull IW.  
Clin Radiol. 2006 May;61(5):393-401.
 Abstract
 
Cerebrospinal Fluid Studies
       
      Journal Papers, Abstracts, and Commentaries  
 
 
Cerebrospinal Fluid Proteomic Profiling of HIV-1-Infected Patients with Cognitive Impairment.
Rozek W, Ricardo-Dukelow M, Holloway S, et al 
J Proteome Res. 2007 Oct 12;
 Abstract
 
Treatment Benefit on Cerebrospinal Fluid HIV-1 Levels in the Setting of Systemic
Virological Suppression and Failure.
Spudich S, Lollo N, Liegler T, et al
J Infect Dis. 2006 Dec 15;194(12):1686-1696
Abstract
 
FULL-TEXT PDF ARTICLE
 Cerebrospinal fluid HIV infection and pleocytosis: Relation to systemic infection and
antiretroviral treatment.
Spudich SS, Nilsson AC, Lollo ND, Liegler TJ, et al
BMC Infect Dis. 2005 Nov 2;5(1):98
 Paper
 
FULL-TEXT PDF ARTICLE
 Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption
in HIV-1 infection.
 Gisslen M, Rosengren L, Hagberg L, et al   
AIDS Res Ther. 2005 Aug 18;2(1):6
 Paper

Progression to neuropsychological impairment in human immunodeficiency virus infection
predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA.
Ellis RJ, Moore DJ, Childers ME, et al
Arch Neurol 2002 Jun;59(6):923-8 
Abstract
 
      Conference Reports, Abstracts, and Posters
 
  Cerebrospinal Fluid HIV Infection in Relation to Systemic Infection and Treatment in Different
Stages of HIV Disease
G Arendt, T Nolting, C Frisch, et al
(13 CROI)
 Abstract
Spinal Cord Disorders
       
      Journal Papers, Abstracts, and Commentaries  
 
  Chronic inflammation causing spinal cord compression in human immunodeficiency virus infection.
Grasso G, Meli F, Graziano F, et a
Med Sci Monit. 2008 Nov;14(11):CS134-137
 Abstract
Immune Reconstitution Syndrome
       

          Journal Papers, Abstracts, and Commentaries
 
  Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients.
Venkataramana A, Pardo CA, McArthur JC, et al  
Neurology. 2006 Aug 8;67(3):383-8.
Abstract
Leukoencephalopathy    Multifocal Leukoencephalopathy
       

          Conference Reports, Abstracts, and Posters

  POSTER
 Predictive Indicators of Disease Progression in HAART-treated Patients with HIV-related
Leukoencephalopathies
S Delbue, M Saresella, E Marchioni, et al
 (13 CROI )
 PDF Poster     Abstract
Myelopathy
       
      Journal Papers, Abstracts, and Commentaries  
 
 
Recurrent vacuolar myelopathy in HIV infection.
Anneken K, Fischera M, Evers S, et al 
J Infect. 2005 Nov 4;
 Abstract
 
Treatment of AIDS-associated myelopathy with L-methionine: A placebo-controlled study.
Di Rocco A, Werner P, Bottiglieri T, et al 
Neurology. 2004 Oct 12;63(7):1270-1275.
 Abstract

FULL-TEXT ARTICLE
Human T-lymphotropic Virus Type I-associated Myelopathy/Tropical Spastic Paraparesis:
Therapeutic Approach
 Mora CA , Mitsuhiro Osame M, Jacobson S 
Current Treatment Options in Infectious Diseases 2003, 5:443-455
Paper
 
FULL-TEXT ARTICLE
HIV-associated Myelopathy
Di RoccoA
Current Treatment Options in Infectious Diseases 2003, 5:457-465
 Paper

CNS Lymphomas
       
         Journal Papers, Abstracts, and Commentaries
 
 
FULL-TEXT PDF ARTICLE
 AIDS-related primary central nervous system lymphoma: a Norwegian national survey 1989-2003.
Haldorsen IS, Krakenes J, Goplen AK, et al
BMC Cancer. 2008 Aug 6;8(1):225.
 Paper
 
Treatment patterns and prognosis in patients with human immunodeficiency virus and primary
central system lymphoma.
Kreisl TN, Panageas KS, Elkin EB, et al
Leuk Lymphoma. 2008 Jul 25:1-7.
 Abstract
 
Remission of progressive multifocal leukoencephalopathy and primary central nervous system
lymphoma in an HIV-infected patient.
Lima MA, Katz-Brull R, Lenkinski RE, et al
Eur J Neurol. 2007 Jun;14(6):598-602.
Abstract
 
FULL TEXT ARTICLE
 HIV Patients Developing Primary CNS Lymphoma Lack EBV-Specific CD4+ T Cell Function
Irrespective of Absolute CD4+ T Cell Counts.
Gasser O, Bihl FK, Wolbers M, et al
PLoS Med. 2007 Mar; 4(3): e96.
Paper
 
FULL TEXT ARTICLE
 Do CD4+ T Cell Functional Responses to Epstein–Barr Virus Provide Protective Immunity
Against CNS Lymphoma in AIDS?
Jacobson MA.  
PLoS Med. 2007 Mar; 4(3): e110
 Paper
 
AIDS-Related Primary Central Nervous System Lymphoma.
Kasamon YL, Ambinder RF.  
Hematol Oncol Clin North Am. 2005 Aug;19(4):665-87
 Abstract
 
Primary central nervous system lymphomas in AIDS patients
Corti M, Villafane F, Trione N, et aL   
Enferm Infecc Microbiol Clin. 2004 Jun;22(6):332-336.
 Abstract
 
Survival is prolonged by highly active antiretroviral therapy in AIDS patients with primary
central nervous system lymphoma.
Skiest DJ, Crosby C.
 AIDS. 2003 Aug 15;17(12):1787-93.
Abstract

T type primary lymphoma of the central nervous system in immunocompetent patients
Barrena MR, Blanch Labrador M,  Gimenez Mas JA, et al.
Rev Neurol 2003 Jul 16;36:125-130
 Abstract

  

          Conference Reports, Abstracts, and Posters

 
Significant survival improvement in AIDS-related primary central nervous system lymphoma
with combined high dose intravenous Methothrexate and HAART
T. Lukiana, F. Lamontagne, A. Mouligner, et al
 (XVI  International AIDS Conference)
Abstract

The management of meningeal lymphoma in patients with HIV in the era of HAART
Mazhar D., Stebbing J., Holmes P
 (XVI  International AIDS Conference)
Abstract

Visual loss as the presenting feature of primary CNS lymphoma (PCNSL) despite
immunological response to HAART
G. Nair, N. Padayatchi, K. Naidoo, et al
 (XVI  International AIDS Conference)
Abstract
 
HIV sequence evolution in the brain: Distinctly different evolutionary pathways between
HAD and primary CNS lymphoma associated strains of HIV
McGrath M.S., Lamers S.L., Salemi M.
 (3rdIAS)
Abstract
Neurocysticercosis
       

          Journal Papers, Abstracts, and Commentaries
 
  Neurocysticercosis in the HIV Era: A Case Report and Review of the Literature.
Serpa JA, Moran A, Goodman JC, et al
Am J Trop Med Hyg. 2007 Jul;77(1):113-117.
 Abstract
Paraparesis
       

          Journal Papers, Abstracts, and Commentaries
 
  Human T lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis
in an HIV-positive patient coinfected with human T lymphotropic virus type 2 following
initiation of antiretroviral therapy.
Toro C, Blanco F, García-Gascó P, et al
Clin Infect Dis. 2007 Nov 1;45(9)
 Abstract

Nervous System  Main Page Main New/Newsworthy Home Page

HIV-Associated Central Nervous System Disorders